Author

Yuqi Kang

Fred Hutch Cancer CenterORCID 0000-0003-0246-248XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Marina ChaniD· 2 shared Taranjit S. GujraliD· 2 shared Aya MiyakiiD· 1 shared Elizabeth R. LawloriD· 1 shared Emma D. WrenniD· 1 shared Jonah R. Valenti· 1 shared Michael A. ZageriD· 1 shared Neerja KatiyariD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Marina ChanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 2, 2025

Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion Kinase

Shireen S. Ganapathi, Emma D. Wrenn, Nicolas M. Garcia…·Elizabeth R. Lawlor

This study shows that BET inhibitor treatment rewires Ewing sarcoma transcription, increasing dependency on FAK, and that combining BET and FAK inhibitors synergistically reduces tumor growth.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Systems BiologyeLifePeer-reviewedOct 27, 2023

KinCytE- a Kinase to Cytokine Explorer to Identify Molecular Regulators and Potential Therapeutic Opportunities

Marina Chan, Yuqi Kang, Shannon Osborne…·Taranjit S. Gujral

KinCytE links kinase inhibitors to cytokine/chemokine signaling networks to identify therapeutic opportunities for difficult-to-drug targets.

3 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky